AlphaStocks
5.5
Consider Buy

Fortrea Holdings Inc. (FTRE)

As of Sep 20, 2026, Fortrea Holdings Inc. (FTRE) scores 5.5/10 on AlphaStocks' five-model composite, #73 of 168 Health Care stocks. At $20, FTRE trades 25% below its model fair value of $27.

Health Care / Biotechnology

S&P SmallCap 600

$19.93

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#73out of 168 in Health Care

Is Fortrea Holdings Inc. a Good Investment in 2026?

Fortrea Holdings Inc. (FTRE) scores 5.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model is the most favorable, rating Fortrea Holdings Inc. as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -34.9% · ROC -91%. Fortrea Holdings Inc. currently trades 25% below its estimated fair value of $27. Fortrea Holdings Inc. ranks #73 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-46.9Market Cap2B

Estimated Fair Value

$26.7025% below

Trading below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Caution

Earnings yield -34.9% · ROC -91%

Frequently Asked Questions

Is Fortrea Holdings Inc. (FTRE) a good investment?
As of Sep 20, 2026, Fortrea Holdings Inc. (FTRE) scores 5.5/10 on AlphaStocks' five-model composite, #73 of 168 Health Care stocks. At $20, FTRE trades 25% below its model fair value of $27. That is a middle-of-the-pack score with no strong signal either way.
What is Fortrea Holdings Inc.'s Piotroski F-Score?
Fortrea Holdings Inc.'s Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is FTRE overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $27, FTRE appears undervalued. The stock currently trades 25% below its estimated fair value. Trading below estimated fair value.
How does FTRE compare to other Health Care stocks?
Fortrea Holdings Inc. ranks #73 out of 168 stocks in the Health Care sector, placing it in the top 43% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about FTRE?
AlphaStocks evaluates FTRE using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.5/10.

Similar Stocks

ABBVINCYHRMY

Compare FTRE with

ABBV vs FTREFTRE vs INCYFTRE vs HRMY

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer